August 9th news, Sinopharm shares announced on the morning of August 9th that the company noticed that on August 8th, news about Shanxi Aorui Biomaterials Co., Ltd. suspected of illegally producing "allogeneic bone implantation materials" appeared on the Internet, which aroused widespread concern in the society, and some media erroneously recorded that Sinopharm shares were involved. In order to avoid misleading investors, the relevant situation is explained as follows: The main body of the relevant media reports is non-Sinopharm shares. Sinopharm shares' main business is pharmaceutical wholesale, mainly drug management. Sinopharm shares and Shanxi Aorui Biomaterials Co., Ltd. do not have business contacts, nor do they have any relationship.